Avinger (NASDAQ:AVGR) Now Covered by StockNews.com

StockNews.com began coverage on shares of Avinger (NASDAQ:AVGR) in a research note issued to investors on Wednesday. The firm issued a hold rating on the medical device company’s stock.

Avinger Price Performance

Shares of AVGR opened at $0.47 on Wednesday. The business has a 50-day simple moving average of $0.51 and a two-hundred day simple moving average of $0.74. Avinger has a 52 week low of $0.36 and a 52 week high of $4.37. The stock has a market cap of $1.57 million, a price-to-earnings ratio of -0.04 and a beta of 1.09.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.